RANUNCULACEAE Nigella sativa  L.

 Synonym

    none ...
 Thai / English name

  • เทียนดำ*

[1-2] of 2 article(s) found

 หน้า  1  

[1] THYMOQUINONE INHIBITS GROWTH AND AUGMENTS 5-FLUOROURACIL-INDUCED APOPTOSIS IN GASTRIC CANCER CELLS BOTH IN VITRO AND IN VIVO.
LEI,XIAOFEI;LV,XIAOGUANG;LIU,MENG;ET AL.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 2012 Vol.417(2),864-8  $41964 [Full]

Part Used : ไม่ระบุ
Activity : APOPTOSIS INDUCTION
Solvent/Active Compound : Thymoquinone
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 50 micromolars
Duration : -
Type of interaction : Pharmacodynamics
Interaction with drug : 5-fluorouracil (5-FU)*/Fluorouracil/FU
Dose/Conc.(drug) : 75 micrograms/mL
Result : Positive
Remark : Type of experiment: gastric cancer cell lines Results: Pretreatment with Thymoquinone (TQ) significantly increased the apoptotic effects induced by 5-fluorouracil (5-FU) in gastric cancer cell lines in vitro. TQ enhanced the 5-FU-induced killing of gastric cancer cells by mediating the downregulation of the anti-apoptotic protein bcl-2, the upregulation of the pro-apoptotic protein bax, and the activation of both caspase-3 and caspase-9.

[2] COMBINATORIAL EFFECTS OF THYMOQUINONE ON THE ANTI-CANCER ACTIVITY OF DOXORUBICIN.
EFFENBERGER-NEIDNICHT,KATHARINA;SCHOBERT,RAINER.
CANCER CHEMOTHER PHARMACOL 2011 Vol.67(4),867-74  $56021 [Full]

Part Used : น้ำมันหอมระเหย
Activity : APOPTOSIS INDUCTION
Solvent/Active Compound : thymoquinone
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : -
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : -
Remark : type of experiment: Doxorubicin, thymoquinone and equimolar mixtures of both were tested for cytotoxicity on human cells of HL-60 leukaemia, 518A2 melanoma, HT-29 colon, KB-V1 cervix, and MCF-7 breast carcinomas as well as multi-drug-resistant variants thereof and on non-malignant human fibroblasts (HF). Results: Thymoquinone improved the anti-cancer properties of doxorubicin in a cell line-specific manner. We found a significant rise of the growth inhibition by doxorubicin in HL-60 and multi-drug-resistant MCF-7/TOPO cells when thymoquinone had been added.


 หน้า  1